Branislava Janic, PhD

Biographical Statement

Dr. Janic is a research scientist in the Radiation Oncology Department at Henry Ford Cancer. She is an expert in cellular and molecular biology with a special interest in cancer cell biology and tumor immunology. She earned her Ph.D. in cellular and molecular physiology at the Pennsylvania State University, College of Medicine and completed post-doctoral training in immunology and retinal stem cell biology at the University of Miami, School of Medicine. Dr. Janic joined Henry Ford as a post-doctoral fellow in 2006.

Research Interests

• Mechanisms of cancer radiotherapy resistance and immune evasion. 
• Current work focuses on developing radio-sensitizing and immunomodulating therapeutic strategies in mouse breast cancer models. She employs triple negative breast cancer mouse model to explore the potential of gold nanoparticles and various molecular inhibitors in overcoming radiotherapy resistance through modulation of immune and antigenic tumor properties.
• Superparamagnetic iron oxide nanoparticles (SPION) and pH sensitive paramagnetic nanoparticles use as diagnostics and/or therapeutics in various animal models for cancer, vascular and immune pathologies. In these models, she uses cell transplantation strategies in analyzing various types of immune, stem and progenitor cells as therapeutic and MRI imaging probes. 
• Extensive expertise in applying radiation for in vivo assessment of tumor radiobiology; MRI, nuclear medicine, optical and fluorescence imaging methods for in vivo cellular tracking and assessment of therapeutic effects of administered cells.
• Cellular and molecular cancer biology.
• Tumor biology. 
• Radiation therapy
• Stem cell biology.
• MRI and optical imaging.
• Cell tracking.

Email: bjanic1@hfhs.org